CoChat

The cost‐effectiveness of the Dose Adjustment for Normal Eating (DAFNE) structured education programme: an update using the Sheffield Type 1 Diabetes Policy Model

Kruger, J., Brennan, A., Thokala, P., Basarir, H., Jacques, R., Elliott, J., Heller, S., Speight, J. · 2013 · Diabetic Medicine
Cited by 42

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Aims: To estimate the cost‐effectiveness of training in flexible intensive insulin therapy [as provided in the Dose Adjustment for Normal Eating (DAFNE) structured education programme] compared with no training for adults with Type 1 diabetes mellitus in the UK using the Sheffield Type 1 Diabetes Policy Model. Methods: The Sheffield Type 1 Diabetes Policy Model was used to simulate the development of long‐term microvascular and macrovascular diabetes‐related complications and the occurrence of diabetes‐related adverse events in 5000 adults with Type 1 diabetes. Total costs and quality‐adjusted life years were estimated from a National Health Service perspective over a lifetime horizon, discounted at a rate of 3.5%. The treatment effectiveness of DAFNE was modelled as a reduction in HbA 1c that affected the risk of developing long‐term diabetes‐related complications. Probabilistic and structural sensitivity analyses were conducted. Results: DAFNE resulted in greater life expectancy and reduced incidence of some diabetes‐related complications compared with no DAFNE.DAFNE was found to generate an average of 0.0294 additional quality‐adjusted life years for an additional cost of £426 per patient, leading to an incremental cost‐effectiveness ratio of £14 400 compared with no DAFNE. There was a 54% probability that DAFNE would be cost‐effective at a willingness‐to‐pay threshold of £20 000 per quality‐adjusted life year. Conclusions: The results of this study suggest that DAFNE is a cost‐effective structured education programme for people with Type 1 diabetes and support its provision by the National Health Service in the UK.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dme.12270

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 42

Metadata

Authors
Kruger, J., Brennan, A., Thokala, P., Basarir, H., Jacques, R., Elliott, J., Heller, S., & Speight, J.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2013-08-19
Volume
30
Issue
10
Pages
1236-1244
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W1985573624
Cited by
42
References
5
FWCI
10.09
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.